UBE2I and head and neck neoplasm: In addition to the therapeutic implications, our findings also indicate that UBC9 could be a useful biomarker not only for cervical progression [26], but also to monitor and to identify pre-cancerous stages in HNC (Fig 1), extending previous observation made in head and neck tumor tissues [58].